Evidence map›Paper›PMID 29967397›Full record

ArticleHeredity2018

Unraveling the causes of adaptive benefits of synonymous mutations in TEM-1 β-lactamase.

Mark P Zwart, Martijn F Schenk, Sungmin Hwang, Bertha Koopmanschap, Niek de Lange, Lion van de Pol, Tran Thi Thuy Nga, Ivan G Szendro, Joachim Krug, J Arjan G M de Visser

Open access · hybridAbstract read
In one paragraph

Article in Heredity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Global genomic epidemiology ofMicrobial genomics · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Synonymous edits in theProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Mark P ZwartInstitute for Theoretical Physics, University of Cologne, Cologne, Germany. m.zwart@nioo.knaw.nl.
Martijn F SchenkInstitute for Theoretical Physics, University of Cologne, Cologne, Germany.
Sungmin HwangInstitute for Theoretical Physics, University of Cologne, Cologne, Germany.
Bertha KoopmanschapLaboratory of Genetics, Wageningen University, Wageningen, The Netherlands.
Niek de LangeLaboratory of Genetics, Wageningen University, Wageningen, The Netherlands.ORCID 0000-0002-5819-4675
Lion van de PolLaboratory of Genetics, Wageningen University, Wageningen, The Netherlands.
Tran Thi Thuy NgaLaboratory of Genetics, Wageningen University, Wageningen, The Netherlands.
Ivan G SzendroInstitute for Theoretical Physics, University of Cologne, Cologne, Germany.
Joachim KrugInstitute for Theoretical Physics, University of Cologne, Cologne, Germany.
J Arjan G M de VisserLaboratory of Genetics, Wageningen University, Wageningen, The Netherlands.
Wageningen University & Research · NLUniversity of Cologne · DEUniversité Paris-Sud · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While synonymous mutations were long thought to be without phenotypic consequences, there is growing evidence they can affect gene expression, protein folding, and ultimately the fitness of an organism. In only a few cases have the mechanisms by which synonymous mutations affect the phenotype been elucidated. We previously identified 48 mutations in TEM-1 β-lactamase that increased resistance of Escherichia coli to cefotaxime, 10 of which were synonymous. To better understand the molecular mechanisms underlying the beneficial effect of these synonymous mutations, we made a series of measurements for a panel containing the 10 synonymous together with 10 non-synonymous mutations as a reference. Whereas messenger levels were unaffected, we found that total and functional TEM protein levels were higher for 5 out of 10 synonymous mutations. These observations suggest that some of these mutations act on translation or a downstream process. Similar effects were observed for some small-benefit non-synonymous mutations, suggesting a similar causal mechanism. For the synonymous mutations, we found that the cost of resistance scales with TEM protein levels. A resistance landscape for four synonymous mutations revealed strong epistasis: none of the combinations of mutations exceeded the resistance of the largest-effect mutation and there were synthetically neutral combinations. By considering combined effects of these mutations, we could infer that functional TEM protein level is a multi-dimensional phenotype. These results suggest that synonymous mutations may have beneficial effects by increasing the expression of an enzyme with low substrate activity, which may be realized via multiple, yet unknown, post-transcriptional mechanisms.

Indexed as

MutationAdaptation, PhysiologicalAllelesAnti-Bacterial Agentsbeta-LactamasesCefotaximeDrug Resistance, BacterialEpistasis, GeneticEscherichia coliGenetic FitnessHumansAnti-Bacterial Agentsbeta-Lactamasesbeta-lactamase TEM-1Cefotaxime

Identifiers

PMID29967397
PMCPMC6180035
OpenAlexW2810811976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.